AI English summary of an SEC filing — figures as filed
HCA Healthcare HCAThe company said net income attributable to HCA Healthcare, Inc. totaled $5.242 billion ($18.97 per diluted share) in 2023, compared with $5.643 billion ($19.15 per share) in 2022. Results for 2022 included gains on sales of facilities of $1.301 billion.
Key points
AI summaryThe company said net income attributable to HCA Healthcare, Inc. totaled $5.242 billion ($18.97 per diluted share) in 2023, compared with $5.643 billion ($19.15 per share) in 2022. Results for 2022 included gains on sales of facilities of $1.301 billion.
HCA Healthcare said revenues rose 7.9% to $64.968 billion in 2023 from $60.233 billion in 2022. The company cited a 4.9% increase in equivalent admissions and a 2.8% increase in revenue per equivalent admission as the main factors.
The company said cash provided by operating activities totaled $9.431 billion in 2023, up $909 million from $8.522 billion in 2022. Capital expenditures excluding acquisitions were $4.744 billion in 2023, and planned capital expenditures for 2024 are expected to be between $5.1 billion and $5.3 billion.
The company said it used $3.811 billion to repurchase common stock and $661 million to pay dividends in 2023. As of December 31, 2023, $775 million remained under the repurchase authorization approved in January 2023.
Key figures
Fiscal year ended December 31, 2023
- Revenue
- $65.0B
- Net income
- $5.2B
- EPS
- $18.97
- Operating cash flow
- $9.4B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
2023 Net Income and Diluted Earnings Per Share
The company said net income attributable to HCA Healthcare, Inc. totaled $5.242 billion ($18.97 per diluted share) in 2023, compared with $5.643 billion ($19.15 per share) in 2022. Results for 2022 included gains on sales of facilities of $1.301 billion.
Source · Based on the MD&A text of the filing
2023 Revenue $64.968 billion
HCA Healthcare said revenues rose 7.9% to $64.968 billion in 2023 from $60.233 billion in 2022. The company cited a 4.9% increase in equivalent admissions and a 2.8% increase in revenue per equivalent admission as the main factors.
Source · Based on the MD&A text of the filing
Operating Cash Flow and Capital Expenditures
The company said cash provided by operating activities totaled $9.431 billion in 2023, up $909 million from $8.522 billion in 2022. Capital expenditures excluding acquisitions were $4.744 billion in 2023, and planned capital expenditures for 2024 are expected to be between $5.1 billion and $5.3 billion.
Source · Based on the MD&A text of the filing
Share Repurchases and Dividends
The company said it used $3.811 billion to repurchase common stock and $661 million to pay dividends in 2023. As of December 31, 2023, $775 million remained under the repurchase authorization approved in January 2023.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…